Latest filing published 30 Jun 2021 for NeueHealth, Inc., €40k.
Insider track record
Sanjeev K. Srivastava: trading record in brief
Sanjeev K. Srivastava (chief executive) discloses dealings in 2 companies, chiefly Magellan Health Inc and NeueHealth, Inc. Over a trading history stretching from 5 March 2015 to 6 May 2021, the count stands at 8 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 30 June 2021 with an option exercise (€40k) in NeueHealth, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Sanjeev K. Srivastava
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 27,180 shares@ US$1.774.4% of flowCommon StockSEC:0001415889-21-003303:1
- 593,748 shares@ US$1.773100.0% of flowCommon StockSEC:0001415889-21-003303:0
- 7,577 shares0Ordinary Common Stock, $0.01 par valueSEC:0001209191-18-018462:0
- 3,516 shares@ US$104.0090.7% of flowOrdinary Common Stock, $0.01 par valueSEC:0001209191-18-018462:1
- 469 shares@ US$67.309.3% of flowOrdinary Common Stock, $0.01 par valueSEC:0001209191-17-019064:1
- 1,338 shares0Ordinary Common Stock, $0.01 par valueSEC:0001209191-17-019064:0
- 670 shares0Ordinary Common Stock, $0.01 par valueSEC:0001140361-15-011014:0
- 246 sharesOrdinary Common Stock, $0.01 par valueSEC:0001140361-15-011014:1
8 of 8 declarations
